Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020

Go back to Gilead Presents New Data from Antiviral Development Programs at IDWeek 2020
Gilead Sciences (NASDAQ: GILD) Delayed: 121.67 -3.83 (3.05%)
Previous Close $125.50    52 Week High $108.63 
Open $125.64    52 Week Low $71.39 
Day High $125.64    P/E 67.22 
Day Low $121.57    EPS $1.81 
Volume 5,363,283